Selective Laser Trabeculoplasty in Controlled Uveitis with Steroid-Induced Glaucoma

Maleki, Arash; Swan, Robert T.; Lasave, Andrés F.; Ma, Lina; Foster, C. Stephen

doi:10.1016/j.ophtha.2016.07.027

Cited by 36 publications

(14 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These findings also suggest that SLT probably could be tried in younger patients with other causes of glaucoma, such as steroid-induced glaucoma, or those developing secondary glaucoma after undergoing vitreoretinal surgery at a young age. 25,26 Results of this study are also important for young women and girls in the reproductive age group and for those who are pregnant with uncontrolled POAG.…”

Section: Discussionmentioning

confidence: 95%

Selective laser trabeculoplasty for primary open-angle glaucoma patients younger than 40 years

Gupta

Ghosh

Sujeeth

et al. 2018

Canadian Journal of Ophthalmology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 95%

Selective laser trabeculoplasty for primary open-angle glaucoma patients younger than 40 years

Gupta

Ghosh

Sujeeth

et al. 2018

Canadian Journal of Ophthalmology

View full text Add to dashboard Cite

show abstract

“…This procedure is an effective alternative to increasing medication or invasive procedures due to its cost‐effectiveness, absence of major adverse effects, and simplicity . It is recommended for eyes with mild to moderate UG with an IOP between 20 and 40 mmHg …”

Section: Treatment and Managementmentioning

confidence: 99%

Overcoming diagnostic and treatment challenges in uveitic glaucoma

Sherman

Cafiero-Chin

2019

Clinical and Experimental Optometry

View full text Add to dashboard Cite

Uveitic glaucoma is a range of disorders that results in optic nerve damage from elevated intraocular pressure secondary to intraocular inflammation. As compared to primary open angle glaucoma, uveitic glaucoma is associated with a more aggressive disease course caused by very high intraocular pressure levels that wax and wane. Diagnosis is often based on clinical presentation, disease course, and associated systemic manifestations. Diagnostic imaging plays an important role in both diagnosis and management. While the mechanisms of uveitic glaucoma vary, treatment requires strict control of the inflammation and may involve additional intraocular pressure lowering techniques. Management often dictates an interdisciplinary approach as systemic association and treatment is common. When topical management does not slow the progression of optic nerve damage and vision loss, surgical intervention is required. A significant portion of patients with uveitic glaucoma will eventually require surgical intervention and the appropriate referrals should be made. By nature, success rates of surgical intervention in uveitic glaucoma patients are lower than non-inflammatory causes of elevated intraocular pressure and glaucomatous damage. Chronic inflammation, multiple mechanisms, systemic associations, and unpredictable response to treatment make uveitic glaucoma challenging to manage. This review will discuss the pathophysiology, diagnosis, and management of uveitic glaucoma to provide a guide for eye-care providers.

show abstract

“…Few retrospective studies have demonstrated the safety and efficacy of SLT in treating different types of secondary glaucoma. [ 73 74 ] In a retrospective case series of 15 eyes with well-controlled uveitis with fluocinolone acetonide intravitreal implant and implant-induced steroid glaucoma. Seven eyes (46.7%) of seven patients achieved an IOP of < 22 mmHg and/or a 20% or greater IOP reduction from the pre-SLT IOP at 1, 6, and 12 months of follow-up period.…”

Section: Micropulse Diode Laser Trabeculoplasty (Mdlt)mentioning

confidence: 99%